Alcon Reports Strong Q4 and Full Year 2025 Financial Results

GENEVA—Alcon (SIX/NYSE:ALC), a global leader in eyecare, has announced its financial results for the three- and twelve-month periods ending December 31, 2025. For the fourth quarter of 2025, sales were $2.7 billion, up 9 percent on a reported basis and up 7 percent on a constant currency basis, compared with the same quarter of the previous year. Reported net sales for the full-year 2025 were $10.3 billion, up 5 percent compared with full-year 2024. Excluding favorable currency impacts of 1 percent, sales were up 4 percent on a constant currency basis, the announcement said.